{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:22:24Z","timestamp":1775172144252,"version":"3.50.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,13]]},"DOI":"10.1093\/sleep\/zsac042","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T10:14:45Z","timestamp":1655115285000},"source":"Crossref","is-referenced-by-count":1,"title":["Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-3752","authenticated-orcid":false,"given":"Clete A","family":"Kushida","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center , Palo Alto, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[{"name":"Sleep Disorders and Research Center, Henry Ford Health System , Detroit, MI , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M","family":"Shapiro","sequence":"additional","affiliation":[{"name":"University of Toronto , Toronto, ON , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Roy","sequence":"additional","affiliation":[{"name":"Ohio Sleep Medicine and Neuroscience Institute , Dublin, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Neurotrials Research, Inc. , Atlanta, GA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinyemi O","family":"Ajayi","sequence":"additional","affiliation":[{"name":"Florida Pediatric Research Institute , Winter Park, FL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Seiden","sequence":"additional","affiliation":[{"name":"Avadel Pharmaceuticals , Chesterfield, MO , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gudeman","sequence":"additional","affiliation":[{"name":"Avadel Pharmaceuticals , Chesterfield, MO , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2022070813284790500_CIT0001","volume-title":"Special Protocol Assessment\u2014Guidance for Industry","author":"US Food and Drug Administration","year":"2018"},{"key":"2022070813284790500_CIT0002","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab072.488","article-title":"Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy","author":"Kushida","year":"2021","journal-title":"Sleep."},{"issue":"1","key":"2022070813284790500_CIT0003","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","author":"U.S. Xyrem Multicenter Study Group","year":"2002","journal-title":"Sleep."},{"key":"2022070813284790500_CIT0004","volume-title":"XYREM (sodium oxybate oral solution, CIII). Full Prescribing Information","author":"Jazz Pharmaceuticals","year":"2020"},{"key":"2022070813284790500_CIT0005","volume-title":"XYWAV (calcium, magnesium, potassium, and sodium oxybates). Full Prescribing Information","author":"Jazz Pharmaceuticals","year":"2021"},{"key":"2022070813284790500_CIT0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2020.09.017","article-title":"The sodium in sodium oxybate: is there cause for concern?","volume":"75","author":"Avidan","year":"2020","journal-title":"Sleep Med."},{"issue":"35","key":"2022070813284790500_CIT0007","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa586","article-title":"Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake","volume":"41","author":"O\u2019Donnell","year":"2020","journal-title":"Eur Heart J."}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/6\/zsac042\/44651116\/zsac042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/6\/zsac042\/44651116\/zsac042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:29:03Z","timestamp":1657286943000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsac042\/6604255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsac042","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"value":"0161-8105","type":"print"},{"value":"1550-9109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,6,1]]},"article-number":"zsac042"}}